Literature DB >> 6725132

Long-term results and complications of proximal interphalangeal arthrodesis in horses.

G S Martin, C W McIlwraith, A S Turner, A J Nixon, T S Stashak.   

Abstract

A retrospective study was made of 21 horses in which proximal interphalangeal arthrodesis had been performed. The right hindlimb was the most often affected (52%). Acute trauma was the most common reason for performing the surgery (62%). Follow-up data were obtained from the owners regarding return to serviceability . When available, follow-up radiographs and clinical examinations were reviewed. Of the 20 horses on which follow-up information was available, 16 were serviceable . Of the horses in which a hindlimb was arthrodesed , 86% were serviceable , whereas 67% of the horses affected in the forelimb were serviceable . An average of 1 year was required for return to serviceability . Follow-up radiography of forelimb cases revealed radiographic changes consistent with navicular disease, distal interphalangeal degenerative joint disease, and a bony exostosis off the dorsal surface of the third phalanx; however, these radiographic changes did not correlate well with the owner's assessment of serviceability . Follow-up clinical examination of forelimb cases revealed 2 horses in which the toe came off the ground during weight bearing.

Entities:  

Mesh:

Year:  1984        PMID: 6725132

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

1.  Arthrodesis of the proximal interphalangeal joint affected with septic arthritis in 8 horses.

Authors:  L J Groom; E M Gaughan; J D Lillich; L W Valentino
Journal:  Can Vet J       Date:  2000-02       Impact factor: 1.008

2.  Evaluation of factors associated with surgical site infection in equine proximal interphalangeal joint arthrodesis: 54 cases (2010-2019).

Authors:  Alyssa Daniels; Lynn M Pezzanite; Gregg M Griffenhagen; Dean A Hendrickson
Journal:  Vet Med Sci       Date:  2022-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.